REGISTER now for FREE 
|
FREE patent keyword monitoring and additional FREE benefits. REGISTER now for FREE
|
 
|
|
Drug, Bio-affecting And Body Treating Compositions > Preparations Characterized By Special Physical Form > Matrices > Polysaccharides (e.g., Cellulose, Etc.) Polysaccharides (e.g., Cellulose, Etc.)Polysaccharides (e.g., Cellulose, Etc.) patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.07/05/07 - 20070154558 - Gelled biopolymer based foam Gelled biopolymer based foams are disclosed. The gelled foams comprise a cross-linked biopolymer, preferably alginate; optionally, a foaming agent such as hydroxy propyl methyl cellulose; and a plasticizer, preferably glycerin sorbitol, or a mixture thereof, that forms the predominant portion of the gelled foam. The foams are soft and pliable ... 07/05/07 - 20070154557 - Particulate comprising phytosterols and food compositions comprising said creamer Particulate compositions comprising 10-95% wt of a matrix material and 5-90% wt of fatty matter, wherein said fatty matter comprises 5-100% of phytosterols (and wherein the compositions are preferably low in triglycerides of transunsaturated fatty acids), for use as for example a creamer and/or whitener. The invention also relates to ... 06/28/07 - 20070148248 - Gastric reflux resistant dosage forms Gastric resistant film-forming compositions are described herein. The composition comprises a gastric resistant natural polymer, a film-forming natural polymer, and optionally a gelling agent. Suitable gastric resistant natural polymers include polysaccharides such as pectin and pectin-like polymers. The film-forming composition can be used to prepare soft or hard shell gelatin ... 06/14/07 - 20070134335 - Polypeptides with the capacity to entrap drugs and release them in a controlled way The present application relates to new peptide polymers comprising monomeric units derived from the residues of glutamic acid, aspartic acid and lysine, or their protected derivatives, and which are functionalized through the introduction of side chains containing thiol groups or protected thiol groups. The new peptide polymers can be crosslinked ... 06/14/07 - 20070134334 - Crosslinked polysaccharide microparticles and method for their preparation The present invention provides long-acting sustained-release formulations of drugs such as proteins or peptides, which are injectable, completely biodegradable and safe, as well as ensuring efficient encapsulation of the drugs such as proteins or peptides without inhibiting their biological activity. It is possible to achieve injectable sustained-release formulations that ensure ... 06/07/07 - 20070128288 - Ophthalmic compositions containing a synergistic combination of three polymers Ophthalmic compositions suitable for use as artificial tears or as vehicles for ophthalmic drugs are disclosed. The compositions contain a combination of three polymers that have a synergistic effect on viscosity. ... 06/07/07 - 20070128287 - Dermal composition for external use The object of the present invention is to provide a dermal composition for external use which keeps skin healthy and demonstrates a sufficient effect in treating skin diseases. The present invention relates to a dermal composition for external use, which comprises sodium cromoglycate and a monoester of polyvalent alcohol and ... 06/07/07 - 20070128286 - Production of polymer matrix for delivery (pmd) This invention is a means of production of polymer matrix for delivery. This invention employs amino acid chelated minerals as an ionic cross-linking agent, which forms colloidal solution containing delivery molecules after fully mingling with chitosan-acid solution that contains delivery molecules. This invention uses amino acid chelated minerals and chitosan ... 06/07/07 - 20070128285 - Pharmaceutical composition for oral administration Provided is a pharmaceutical composition for oral administration containing a 5-HT.3 receptor antagonist, which is suitable for self-medication because of good preservation stability, low synthesis, good uniformity and good external appearance, and good smoothness in throat, and easiness to be taken. Concretely, it is a jellied pharmaceutical composition for oral ... 05/17/07 - 20070110814 - Bioconjugates comprising sulfated polysaccharides and their uses The present invention provides bioconjugates comprising a sulfated polysaccharide such as alginate sulfate and hyaluronan sulfate and at least one bioactive polypeptide capable of binding a sulfate group of said sulfated polysaccharide. The bioactive polypeptide can be a heparin-binding polypeptide and/or a positively-charged polypeptide. Also, provided are delivery systems and ... 05/17/07 - 20070110813 - Polycation-polyanion complexes, compositions and methods of use thereof One aspect of the present invention relates to compositions and methods comprising polyelectrolyte molecules for treating patients who have certain diseases. Aspects of the invention relate to using certain polyelectrolyte compositions in therapy. According to the invention polyelectrolyte compositions may be used, for example, to slow or stop cell growth, ... 05/10/07 - 20070104791 - Method of preparing a pharmaceutical composition and pharmaceutical compositions obtainable thereby An aqueous pharmaceutical composition comprising: a) 0.005 to 10% by wt of one or more water-soluble pharmaceutically active ingredients or pharmaceutically acceptable salts thereof; b) from 0.01 to 10% by wt hydroxypropyl methyl cellulose having a viscosity of from 2500 to 5500 cps (mPa·s); and c) a buffer for maintaining ... 04/05/07 - 20070077305 - Biocompatible polymeric matrix and preparation thereof The invention discloses a biocompatible polymeric matrix which is functionalized through the reaction with a functionalizing agent including protonated carboxylic acid groups. There is also disclosed a method of preparation of the polymeric matrix and a pharmaceutical composition including the matrix as a carrier for controlled release of a bioactive ... 03/08/07 - 20070053987 - Cross-linked polysacharide and protein matrices and methods for their preparation Methods for preparing cross-linked polysaccharide matrices by cross-linking one or more amino group containing polysaccharides or amino-functionalized polysaccharides with reducing sugars and/or reducing sugar derivatives. The resulting matrices may include polysaccharide matrices and composite cross-linked matrices including polysaccharides cross-linked with proteins and/or polypeptides. Additives and/or cells may also be included ... 02/08/07 - 20070031501 - Use of recombinant or synthetic gelatin-like proteins as stabiliser in lyophilized pharmaceutical compositions The invention relates to the use of gelatin-like proteins, or polypeptides, with an increased calculated glass transition temperature as stabilisers in lyophilized biological or pharmaceutical compositions. ... 02/01/07 - 20070026075 - Gelled donepezil compositions and methods for making and using the same Gelled donepezil compositions and methods for making and using the same are provided. The subject compositions include a donepezil active agent in a gelled oral pharmaceutically acceptable vehicle comprising an emulsion of water and oil. Also provided are kits of the subject compositions. ... 02/01/07 - 20070026074 - Vaginal treatment composition A vaginal treatment composition that rapidly forms a gel when placed into contact with monovalent or polyvalent cations, such as sodium (Na+) and calcium (Ca2+) cations naturally found in vaginal mucosa, is provided. The gel may form in less than about 1 hour, in some embodiments less than about 1 ... 01/18/07 - 20070014862 - Device for treating wound gaps A hemostatic agent comprises oxidized cellulose in the form of a compressible, shapeable mass that can remain substantially in the compressed or shaped form for placement on a bleed site or into a wound gap. The oxidized cellulose may be a pellet of unwoven oxidized cellulose fibrous strands, or it ... 01/04/07 - 20070003627 - Hemorrhoidal compositions and method of use The present invention is directed to gel compositions useful in the preparation of medicated gel products. Such medicated gel products are suitable for use in the treatment of anorectal disorders such as hemorrhoids. Also disclosed is a method for the treatment of such anorectal disorders using the claimed medicated gel ... 12/21/06 - 20060286172 - Pharmaceutical compositions comprising prostanoid-receptor agonists and methods of making and using the same The present invention is related to pharmaceutical compositions comprising prostanoid-receptor agonists, intravaginal dosage forms comprising the same, and methods of making and using the same. The present invention is also related to a controlled release pharmaceutical gel for vaginal administration, the pharmaceutical gel comprising: (a) misoprostol; (b) a cellulose derivative; ... 11/30/06 - 20060269609 - 6-methylpyridine derivatives, method for preparing thereof and antiviral pharmaceutical composition comprising the same The present invention relates to 6-methylpyridine derivatives useful as an antiviral agent. More particularly, the present invention relates to novel 6-methylpyridine derivatives having an excellent inhibitory effect on replication of Hepatitis C virus (HCV), or pharmaceutically acceptable salts thereof, to a method for preparing thereof, and to an antiviral pharmaceutical ... 11/02/06 - 20060246140 - Method for the preparation of molecular complexes The invention relates to a method for the preparation of soluble molecular complexes, comprising one or more active substances which are poorly-soluble in an aqueous medium, included within one or more host molecules, characterised in comprising the following steps: (a) bringing one or more active substances into contact with one ... 10/12/06 - 20060228418 - Topical ointment and method for making and using same A topical ointment comprises a base material of plasticized hydrocarbon gel and methylcellulose in which are dispersed a plurality of microbubbles containing liquid. The microbubbles containing liquid are encapsulated by the base material to form microencapsulations which are dispersed in the base material to form a hydrogel. Application of the ... 08/24/06 - 20060188576 - Pirenzepine ophthalmic gel It is a primary object of the present invention to provide an aqueous ophthalmic formulation, for treating myopia, comprising pirenzepine in combination with a pharmaceutically acceptable gel carrier. ... 08/03/06 - 20060172008 - Freeze-dried fibrin matrices and methods for preparation thereof The present invention relates to porous freeze-dried fibrin matrices substantially devoid of external anti-fibrinolytic agents, and methods of producing such matrices. Resilient matrices, also known as sponges, that are particularly beneficial for supporting three dimensional cell growth are obtained from plasma proteins substantially devoid of plasminogen or from partially purified ... 07/27/06 - 20060165803 - Pharmaceutical compositions of sertaconazole for vaginal use The invention relates to monodose mucoadhesive vaginal compositions of sertaconazole or a pharmaceutically acceptable salt thereof for the treatment of vulvovaginal candidiasis. ... 07/27/06 - 20060165802 - Medium containing water with increased viscosity, method for production and use thereof The invention concerns a water-containing medium with an increased viscosity containing a gellable polymer component with phenolic substituents modified with the aid of oxidases, characterized in that it was modified by a) a protein with polyphenol oxidase activity and/or b) an enzyme mixture containing hydrolases, oxidoreductases and peroxidases. The medium ... 06/15/06 - 20060127483 - Topical drug delivery system The present invention relates to topical drug compositions and methods for topical drug delivery which promote stability of a drug component and facilitate the penetration of the drug component into the skin of the host. The invention also relates to topical drug compositions containing a suitable vasoactive agent, such as ... 06/01/06 - 20060115533 - Pharmaceutical compositions A pharmaceutical composition in the form of a solid dispersion comprising a macrolide, e.g. a rapamycin or an ascomycin, and a carrier medium. ... 05/25/06 - 20060110459 - Triple natural polymer viscoelastic composition A triple natural polymer viscoelastic composition is disclosed. By combining glucosamine sulfate (“GS”), sodium hyaluronate (“HA”) and chondroitin sulfate (“CS”), the triple natural polymer viscoelastic compositions of this invention can provide a viscoelastic agent at a surgical site that not only serves as a protective agent to ocular tissues, but ... 05/25/06 - 20060110458 - Sustained release drug carrier The present invention aims to provide completely biodegradable and biocompatible sustained-release carriers for proteins or peptides, which allow encapsulation of the proteins or peptides at high encapsulation rates without inhibiting their biological activity. The present invention provides a method for preparing a sustained-release carrier, wherein in a solution in the ... 05/11/06 - 20060099268 - Photochemically crosslinked collagen scaffolds and methods for their preparation A method for producing collagen-based scaffolds with improved characteristics, which broadens the usage of collagen in tissue engineering and the products so produced are described. The method comprises reconstitution of three-dimensional collagen matrices from collagen monomer solution and crosslinking the matrix with a light source in the presence of a ... 05/11/06 - 20060099267 - High-dosage extended-release formulation of gepirone The present invention relates to high-dosage extended-release formulation of gepirone and methods of treating major depression by administering the same to a subject in need thereof. More specifically, the present invention relates to a high-dosage extended-release tablet form of gepirone. The present invention also relates to a method of treating ... 05/11/06 - 20060099266 - Slow release formulation of clarithromycin The invention relates to an orally administrable pharmaceutical comprising an alginate matrix consisting of a water-soluble alginate salt and a complex salt of alginic acid, a macrolide, and an inorganic salt characterized in that the inorganic salt is capable of donating a proton and has a pKa value in water ... 04/06/06 - 20060073207 - Protein biomaterials and biocoacervates and methods of making and using thereof The present invention relates to protein biocoacervates and biomaterials and the methods of making and using protein biocoacervates and biomaterials. More specifically the present invention relates to protein biocoacervates and biomaterials that may be utilized for various medical applications including, but not limited to, drug delivery devices for the controlled ... 03/09/06 - 20060051423 - Chitosan-based transport system The invention relates to a chitosan-based transport system for overcoming the blood-brain barrier. This transport system can convey active agents or markers into the brain. The transport system contains at least one substance selected from the group consisting of chitin, chitosan, chitosan oligosaccharides, glucosamine, and derivatives thereof, and optionally one ... 02/02/06 - 20060024373 - Cross-linked hyaluronic acid-laminin gels and use thereof in cell culture and medical implants The present invention concerns universal biocompatible matrices comprising cross-linked hyaluronic acid-laminin gels useful for clinical applications including as implants, for tissue engineering as well as in biotechnology. The gel matrices according to the present invention may be used clinically either per se or as a cell bearing implant, e.g., stem ... 02/02/06 - 20060024372 - High viscosity antibacterials An antibacterial fluid may be applied to a tubular medical cannula for access to a patient. The fluid comprises a typically metabolizable antibacterial formulation having a viscosity preferably greater than 150,000 cp. The cannula may then be inserted into the patient with an increased lubricity for a reduction of pain, ... 01/26/06 - 20060018968 - Use of polyethylene glycol based fluidized polymer suspension in functional systems An aqueous based functional system contains a stable fluid polymer suspension (FPS) thickening agent of a polysaccharide, polyethylene glycol (PEG), and hydrated thickening silica. The functional systems may be formulations of personal care excluding oral care, household care, oil field servicing fluids, Civil Engineering servicing fluids, paper coatings, construction fluids, ... 01/19/06 - 20060013884 - Humidity-dependent antibacterial powdery composition, process for producing the same, humidity-dependent antibacterial food storing article and method of storing food An object of the present invention is to provide a humidity-dependent antibacterial powdery composition of excellent applicability wherein a volatile oily antibacterial substance can be contained in high ratio; a process for producing the same; a humidity-dependent antibacterial food storing article; and a method of storing food. The humidity-dependent antibacterial ... 01/05/06 - 20060003011 - Pharmaceutical compositions of drugs and neutralized acidic polymers Pharmaceutical compositions comprised of low-solubility and/or acid-sensitive drugs and neutralized acidic polymers are disclosed. ... 01/05/06 - 20060003010 - Pharmaceutical formulations for the safe administration of drugs used in the treatment of drug addiction and processes for obtaining the same The present invention provides safe pharmaceutical formulations for drugs used in the treatment of drug addiction, namely formulations which render the abusive administration of the drug contained in these formulations not feasible, together with processes for obtaining said formulations. ... 12/29/05 - 20050287220 - Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same The present invention relates to pharmaceutical compositions in the form of a gel for controlled- or sustained-release of a pharmaceutically active agent and to methods for treating or preventing or preventing a condition in an animal by administering to an animal in need thereof the pharmaceutical compositions. One particular type ... 12/29/05 - 20050287219 - Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same The present invention relates to pharmaceutical compositions in the form of a gel for controlled- or sustained-release of a pharmaceutically active agent and to methods for treating or preventing or preventing a condition in an animal by administering to an animal in need thereof the pharmaceutical compositions. One particular type ... 12/22/05 - 20050281882 - Matrix made of a polysaccharide modified under an electron beam with a functional organosilicon compound Water-soluble or water-dispersible matrix, made of a polysaccharide modified under an electron beam with an organosilicon compound chosen from organosilanes and/or polyorganosiloxanes having at least one functional group capable of reacting and/or interacting with said polysaccharide. Use of the matrix as stabilizing agent in the preparation of simple emulsions, in ... 12/08/05 - 20050271729 - Crosslinking hyaluronan and chitosanic polymers Materials and methods related to crosslinking hyaluronan and chitosan are described herein. Also described are products of the described methods. ... 12/01/05 - 20050266089 - Contact lens and eye drop rewetter compositions and methods Stable ophthalmic formulations comprising hyaluronic acid (sodium hyaluronate) as the primary active demulcent ingredient, stabilized oxy-chloro complex (available commercially as OcuPure™ from Advanced Medical Optics, Purite® from Allergan, and Purogene from Biocide) for preservative efficacy, balanced salts mimicking the tear film, and sodium borate as a buffer are disclosed. In ... 12/01/05 - 20050266088 - Formulation for fast dissolution of lipophilic compounds The present invention relates to a pharmaceutical composition comprising at least one lipophilic compound and at least one glass of a sugar, a sugar alcohol, a mixture of sugars, a mixture of sugar alcohols, or a mixture of at least one sugar and at least one sugar alcohol, wherein the ... 12/01/05 - 20050266087 - Formulations having increased stability during transition from hydrophobic vehicle to hydrophilic medium A suspension formulation for therapeutic use includes a non-aqueous, hydrophobic vehicle exhibiting viscous fluid characteristics, a dry particle formulation comprising a biomolecule dispersed in the vehicle, and a surfactant incorporated in at least one of the vehicle and dry particle formulation. A dry particle formulation includes an interferon, a buffer, ... 11/17/05 - 20050255162 - Hydrophobic biomolecular structure The present invention relates to a new hydrophobe biomolecular structure, which is compacted due to the passing of the structure over its point of collapse, a method for the preparation of the structure and use of the new structure for the manufacture of a medicament. ... 10/27/05 - 20050238723 - Method of producing hydroxyalkyl starch derivatives The present invention relates to methods of producing hydroxyalkyl starch (HAS) derivatives having a structure according to formula (I) comprising reacting HAS of formula (I) at its optionally oxidized reducing end or a HAS derivative, obtainable by reacting HAS of formula (I) at its optionally oxidized reducing end with a ... 10/06/05 - 20050220882 - Materials for medical implants and occlusive devices An embodiment is a swellable medical device that swells after introduction into a patient to occlude a lumen or void in a patient. The device may be anisotropically swellable so that it swells unequally in some dimensions to create an improved fit of the device into the patient. Anisotropically swellable ... 09/22/05 - 20050208141 - Delivery systems for functional ingredients The present invention provides oral delivery systems for functional ingredients, such as drugs, nutritional supplements, botanicals, and vitamins. The delivery systems comprise an ingestible matrix within which the functional ingredient(s) are substantially uniformly and completely dispersed and in which degradation of the functional ingredient(s) is minimised. The matrix comprises 1) ... 09/22/05 - 20050208140 - Short peptide carrier system for cellular delivery of agent A dipeptide or tripeptide carrier system for active agent delivery to cells has an N-terminus natural amino acid and an active agent covalently bonded to a side chain of one of the remaining amino acid bases. The system is amenable to formulation as an oral administrant. The active agent being ... 09/22/05 - 20050208139 - Chemically stable compositions of 4-hydroxy tamoxifen A class of chemically stable 4-hydroxy tamoxifen compositions is characterized by roughly equal amounts of the Z-4-hydroxy tamoxifen and E-4-hydroxy tamoxifen isomers, such that the potency of the compositions is not affected adversely by the isomerization that occurs between these two forms. The inventive compositions are useful for preventing or ... 09/01/05 - 20050191356 - Porous and non-porous matrices based on chitosan and hydroxy carboxylic acids The invention relates to biocompatible matrices based on chitosan and hydroxy carboxylic acids, to multilayer systems comprising these matrices and to applications of such matrices. ... 08/25/05 - 20050186283 - Collagen carrier of therapeutic genetic material, and method A collagen matrix material is charged with a cell growth-promoting derived nucleic acid sequence. The nucleic acid sequence-charged collagen matrix material may be utilized in a method of promoting regeneration of surface cartilage of a joint. In the method, an area of injury is covered with the nucleic acid sequence-charged ... 08/25/05 - 20050186282 - Method and compositions for preparing and delivering lipids, other nutrients and medicaments This invention provides composite gels to, e.g., enhance the palatability of feed supplements, and to efficiently deliver unmodified amino acids, lipids, and/or feed supplements through to the digestive tract of ruminant and non-ruminant animals. The invention also provides methods to make and use composite gels. ... 08/18/05 - 20050181058 - Use of polysaccharides, such as galactomannans, glucomannans and the like for introducing active substances into the human or animal metabolism The use of polysaccharides, such as galactomannans, glucomannans and the like, for introducing active substances into the human or animal metabolism is described. The vital substances, individually or as a complex, are embedded separately and in each case functionally separated from one another in a plant-based matrix of the polysaccharide. ... 08/18/05 - 20050181057 - Vaginal lubricant A vaginal lubricant comprises (i) water, (ii) a DHEA salt, (iii) a polyether, and (iv) a lubricant. The pH of the vaginal lubricant is at least 5.6. ... 08/11/05 - 20050175706 - Sustained release oral formulations Pharmaceutical composition capable of releasing a therapeutically effective dose of active agent, e.g., rivastigmine, in a time-controlled manner. ... 08/11/05 - 20050175705 - Modified reconstituted basement membrane composition for assay system A modified reconstituted extracellular matrix composition is provided herein. The composition includes an extracellular matrix and at least one exogenous component selected from heparin, fibronectin and laminin. The composition may have a basic pH. Additionally, provided herein is a cell culturing system including a substrate and a coating thereon of ... 07/21/05 - 20050158388 - Treatment of gynecomastia with 4-hydroxy tamoxifen The present invention provides methods for treating and preventing gynecomastia by administering 4-hydroxy tamoxifen to a patient. When percutaneously administered to a patient's breasts, 4-hydroxy tamoxifen concentrates locally, and exerts an anti-estrogenic effect. In patients with gynecomastia, this reduces the effective estrogen-androgen ratio in the breast tissue, thereby reducing ductal ... 07/14/05 - 20050152979 - Hydrophobic drug compositions containing reconstitution enhancer Disclosed are compositions comprising a hydrophobic active agent, a polymer and a reconstitution enhancing agent. Reconstitution of the lyophilized form of the compositions takes less time than in the absence of the enhancing agent. ... 06/23/05 - 20050136117 - Pharmaceutical formulations Formulations comprising amoxicillin and clavulanate for reconstitution into an aqueous suspension incorporate low levels of carboxymethylcellulose sodium to stabilise the pH thereof. ... 06/23/05 - 20050136116 - Stabilized prednisolone sodium phosphate solutions A stabilized pharmaceutical prednisolone sodium phosphate solution of prednisolone sodium phosphate stabilized with a stabilizing effective amount of buffering agent and thickening agent. ... 06/16/05 - 20050129772 - Compositions comprising an hiv protease inhibitor The present invention relates to pharmaceutical compositions comprising amorphous (4R)—N-allyl-3-{(2S,3S)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-phenylbutanoyl}-5,5-dimethyl-1,3-thiazolidine-4-carboxamide, or a pharmaceutically acceptable salt or solvate thereof, their methods of preparation, their use in inhibiting the HIV protease enzyme, and their use in treating HIV-infected mammals, such as humans. ... 06/16/05 - 20050129771 - Ophthalmic compositions containing a polysaccharide/borate gelling system Topical ophthalmic compositions that form a gel or partial gel upon application to the eye are described. The compositions are particularly useful as artificial tears and ocular lubricants, but may also be utilized for the topical delivery of pharmaceutically active compounds to the eye. The compositions contain a polysaccharide/borate gelling ... ### FreshPatents.com Support - Terms & Conditions |